Lasa Supergenerics Ltd

NSE: LASA · BSE: 540702 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹5.32
Market cap: ₹26.65 Cr
Revenue (annual): ₹25.14 Cr
Net profit (annual): ₹-34.09 Cr
P/E (TTM): -1.6×Sector 47.4×
Promoter holding: 53.65%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 5 Other Announcement 3 Board Meeting Date 2 Management Change 1 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

16 Apr 2026 16:48 IST BSE

Debt & Borrowing

Lasa Supergenerics Debt & Borrowing

Lasa Supergenerics Limited has declared that it does not fall under the 'Large Corporate' category as per SEBI's framework for fund raising via debt securities. This regulatory disclosure confirms the company's non-applicability to specific debt-raising norms mandated for larger entities.

Read the filing ↗